Brincidofovir (CMX001) is well tolerated in highly immunocompromised pediatric patients Meeting Abstract


Authors: Prasad, V. K.; Grimley, M.; Papanicolaou, G.; Yu, L. C.; Florescu, D. F.; Brundage, T. M.; Mommeja-Marin, H.; Kurtzberg, J.
Abstract Title: Brincidofovir (CMX001) is well tolerated in highly immunocompromised pediatric patients
Meeting Title: 2014 BMT Tandem Meetings
Journal Title: Biology of Blood and Marrow Transplantation
Volume: 20
Issue: 2 Suppl. 1
Meeting Dates: 2014 Feb 26-Mar 2
Meeting Location: Grapevine, TX
ISSN: 1083-8791
Publisher: Elsevier Inc.  
Date Published: 2014-02-01
Start Page: S93
Language: English
ACCESSION: WOS:000331155400111
PROVIDER: wos
DOI: 10.1016/j.bbmt.2013.12.121
Notes: Oral Presentations Meeting Abstract: 106 -- BMT Tandem Meetings -- FEB 26-MAR 02, 2014 -- Grapevine, TX -- 1 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors